These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1874 related articles for article (PubMed ID: 25872544)

  • 21. Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias.
    Kondoh Y; Johkoh T; Fukuoka J; Arakawa H; Tanaka T; Watanabe N; Sakamoto K; Kataoka K; Kimura T; Taniguchi H
    Respir Med; 2015 Mar; 109(3):389-96. PubMed ID: 25682542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How does comorbidity influence survival in idiopathic pulmonary fibrosis?
    Hyldgaard C; Hilberg O; Bendstrup E
    Respir Med; 2014 Apr; 108(4):647-53. PubMed ID: 24529739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
    Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
    Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
    Adegunsoye A; Oldham JM; Bellam SK; Montner S; Churpek MM; Noth I; Vij R; Strek ME; Chung JH
    Ann Am Thorac Soc; 2019 May; 16(5):580-588. PubMed ID: 30653927
    [No Abstract]   [Full Text] [Related]  

  • 28. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.
    Wijsenbeek M; Kreuter M; Olson A; Fischer A; Bendstrup E; Wells CD; Denton CP; Mounir B; Zouad-Lejour L; Quaresma M; Cottin V
    Curr Med Res Opin; 2019 Nov; 35(11):2015-2024. PubMed ID: 31328965
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictors of survival in idiopathic interstitial pneumonia.
    Carbone R; Bottino G; Paredi P; Shah P; Meyer KC
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):695-704. PubMed ID: 20707290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?
    Nurmi HM; Purokivi MK; Kärkkäinen MS; Kettunen HP; Selander TA; Kaarteenaho RL
    BMC Pulm Med; 2017 Jan; 17(1):16. PubMed ID: 28086844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
    Collins BF; Luppi F
    Clin Chest Med; 2021 Jun; 42(2):321-335. PubMed ID: 34024407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
    Ryerson CJ; Vittinghoff E; Ley B; Lee JS; Mooney JJ; Jones KD; Elicker BM; Wolters PJ; Koth LL; King TE; Collard HR
    Chest; 2014 Apr; 145(4):723-728. PubMed ID: 24114524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis.
    Green R; Baldwin M; Pooley N; Misso K; Mölken MPR; Patel N; Wijsenbeek MS
    Respir Res; 2024 Aug; 25(1):325. PubMed ID: 39192278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
    Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
    BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis.
    Kondoh Y; Furukawa T; Hozumi H; Suda T; Egashira R; Jokoh T; Fukuoka J; Kuwana M; Teramachi R; Fujisawa T; Hasegawa Y; Ogura T; Miyazaki Y; Oyama S; Teramukai S; Horiguchi G; Naito A; Inoue Y; Ichikado K; Bando M; Tomioka H; Nishioka Y; Chiba H; Ebina M; Nakanishi Y; Satoh K; Shiratori Y; Hashimoto N; Ishii M
    BMC Pulm Med; 2024 Oct; 24(1):511. PubMed ID: 39396941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
    Alhamad EH; Masood M; Shaik SA; Arafah M
    Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interstitial Lung Disease in the Elderly.
    Patterson KC; Shah RJ; Porteous MK; Christie JD; D'Errico CA; Chadwick M; Triano MJ; Deshpande C; Rossman MD; Litzky LA; Kreider M; Miller WT
    Chest; 2017 Apr; 151(4):838-844. PubMed ID: 27865876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interstitial Lung Disease: A Review.
    Maher TM
    JAMA; 2024 May; 331(19):1655-1665. PubMed ID: 38648021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burden of illness in progressive fibrosing interstitial lung disease.
    Singer D; Bengtson LGS; Conoscenti CS; Anderson AJ; Brekke L; Shetty SS; Brown KK
    J Manag Care Spec Pharm; 2022 Aug; 28(8):871-880. PubMed ID: 35876293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 94.